Together, these results provide evidence for the role of integrin-mediated signalling via the PI3K/AKT pathway in promoting B-ALL cell survival during chemotherapy treatment (summarised in Fig. 1). The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.